Annual Current Liabilities
$8.51 M
-$3.15 M-27.01%
December 31, 2023
Summary
- As of February 21, 2025, RGLS annual total current liabilities is $8.51 million, with the most recent change of -$3.15 million (-27.01%) on December 31, 2023.
- During the last 3 years, RGLS annual current liabilities has fallen by -$3.07 million (-26.52%).
- RGLS annual current liabilities is now -75.82% below its all-time high of $35.19 million, reached on December 31, 2014.
Performance
RGLS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$6.48 M
+$1.22 M+23.16%
September 30, 2024
Summary
- As of February 21, 2025, RGLS quarterly total current liabilities is $6.48 million, with the most recent change of +$1.22 million (+23.16%) on September 30, 2024.
- Over the past year, RGLS quarterly current liabilities has increased by +$1.22 million (+23.16%).
- RGLS quarterly current liabilities is now -81.58% below its all-time high of $35.19 million, reached on December 31, 2014.
Performance
RGLS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RGLS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.0% | +23.2% |
| 3 y3 years | -26.5% | +11.2% |
| 5 y5 years | -68.1% | -69.1% |
RGLS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.0% | +62.8% | -44.4% | +37.9% |
| 5 y | 5-year | -60.6% | +62.8% | -70.0% | +37.9% |
| alltime | all time | -75.8% | +62.8% | -81.6% | +37.9% |
Regulus Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.48 M(+23.2%) |
| Jun 2024 | - | $5.26 M(-7.4%) |
| Mar 2024 | - | $5.68 M(-33.2%) |
| Dec 2023 | $8.51 M(-27.0%) | $8.51 M(+3.2%) |
| Sep 2023 | - | $8.25 M(+0.2%) |
| Jun 2023 | - | $8.23 M(-6.7%) |
| Mar 2023 | - | $8.82 M(-24.3%) |
| Dec 2022 | $11.66 M(+123.0%) | $11.66 M(+10.8%) |
| Sep 2022 | - | $10.52 M(+80.5%) |
| Jun 2022 | - | $5.83 M(+24.0%) |
| Mar 2022 | - | $4.70 M(-10.1%) |
| Dec 2021 | $5.23 M(-54.9%) | $5.23 M(-54.4%) |
| Sep 2021 | - | $11.46 M(+15.0%) |
| Jun 2021 | - | $9.97 M(+1.1%) |
| Mar 2021 | - | $9.86 M(-14.8%) |
| Dec 2020 | $11.58 M(-46.4%) | $11.58 M(-40.6%) |
| Sep 2020 | - | $19.48 M(-7.2%) |
| Jun 2020 | - | $20.98 M(+6.0%) |
| Mar 2020 | - | $19.79 M(-8.4%) |
| Dec 2019 | $21.60 M(-18.9%) | $21.60 M(+2.8%) |
| Sep 2019 | - | $21.00 M(+2.5%) |
| Jun 2019 | - | $20.49 M(-17.5%) |
| Mar 2019 | - | $24.84 M(-6.8%) |
| Dec 2018 | $26.65 M | $26.65 M(+3.9%) |
| Sep 2018 | - | $25.65 M(-16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $30.80 M(-0.4%) |
| Mar 2018 | - | $30.93 M(-5.1%) |
| Dec 2017 | $32.60 M(+136.1%) | $32.60 M(+177.3%) |
| Sep 2017 | - | $11.76 M(+5.7%) |
| Jun 2017 | - | $11.12 M(+5.2%) |
| Mar 2017 | - | $10.58 M(-23.4%) |
| Dec 2016 | $13.81 M(+9.3%) | $13.81 M(+5.0%) |
| Sep 2016 | - | $13.15 M(+18.5%) |
| Jun 2016 | - | $11.10 M(+0.8%) |
| Mar 2016 | - | $11.01 M(-12.8%) |
| Dec 2015 | $12.63 M(-64.1%) | $12.63 M(-14.7%) |
| Sep 2015 | - | $14.81 M(+1.8%) |
| Jun 2015 | - | $14.55 M(+1.4%) |
| Mar 2015 | - | $14.35 M(-59.2%) |
| Dec 2014 | $35.19 M(+239.4%) | $35.19 M(+195.9%) |
| Sep 2014 | - | $11.89 M(+5.6%) |
| Jun 2014 | - | $11.27 M(+17.8%) |
| Mar 2014 | - | $9.57 M(-7.7%) |
| Dec 2013 | $10.37 M(-18.8%) | $10.37 M(-23.3%) |
| Sep 2013 | - | $13.53 M(-28.8%) |
| Jun 2013 | - | $19.00 M(+49.7%) |
| Mar 2013 | - | $12.69 M(-0.6%) |
| Dec 2012 | $12.77 M(-0.6%) | $12.77 M(-4.8%) |
| Sep 2012 | - | $13.41 M(-20.2%) |
| Jun 2012 | - | $16.80 M(+30.7%) |
| Dec 2011 | $12.85 M | $12.85 M |
FAQ
- What is Regulus Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Regulus Therapeutics?
- What is Regulus Therapeutics annual current liabilities year-on-year change?
- What is Regulus Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly current liabilities year-on-year change?
What is Regulus Therapeutics annual total current liabilities?
The current annual current liabilities of RGLS is $8.51 M
What is the all time high annual current liabilities for Regulus Therapeutics?
Regulus Therapeutics all-time high annual total current liabilities is $35.19 M
What is Regulus Therapeutics annual current liabilities year-on-year change?
Over the past year, RGLS annual total current liabilities has changed by -$3.15 M (-27.01%)
What is Regulus Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of RGLS is $6.48 M
What is the all time high quarterly current liabilities for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly total current liabilities is $35.19 M
What is Regulus Therapeutics quarterly current liabilities year-on-year change?
Over the past year, RGLS quarterly total current liabilities has changed by +$1.22 M (+23.16%)